First Foundation Labs, Founded by Luma Group, Collaborates with Microsoft to Bring AI-Powered Clinical and Translational Reasoning to Microsoft Discovery

First Foundation Labs (1FL), a life sciences AI company pioneering clinical and translational reasoning spun out of Luma ...

TD2 Oncology and Panome Bio Partner to Advance Translational Oncology Through Integrated Multi-Omics Capabilities

Panome Bio, a leading multi-omics contract research organization (CRO) and CLIA-certified laboratory, and TD2 Oncology, a ...
TMCnet

Genovyn Appoints Industry Veterans Sammy Bell as Chief Scientific Officer and Jim Edinger as Chief Development Officer to Accelerate AI-Enabled Therapeutic Discovery and ...

As Chief Scientific Officer, Dr. Bell will lead Genovyn’s scientific strategy, AI platform development, scientific integration, discovery enablement, and portfolio prioritization. He will oversee ...

Translational Development Acquisition Corp. Un

Complete Translational Development Acquisition Corp. Un stock information by Barron's. View real-time TDACU stock price and ...
Medicine Buffalo

Defining translational science — and why it matters

“Translational science holds promise to improve health and improve healthcare by speeding the development of the new innovations to get them into clinical use,” says University at Buffalo Clinical and ...

Translational Development Acquisition, ProLogium Announce Nasdaq Merger

Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter Translational Development Acquisition Corp. ( (TDAC)) just unveiled an update. On May ...
U.S. News & World Report

Translational Development Acquisition Corp. - Ordinary Shares- Class A

Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar ...